MedPath

Automated Phonocardiography Analysis in Adults

Completed
Conditions
Aortic Insufficiency
Aortic Stenosis
Insufficiency, Pulmonary
Mitral Insufficiency
Tricuspid Regurgitation
Mitral Insufficiency and Aortic Stenosis
Insufficiency, Tricuspid
Registration Number
NCT03600051
Lead Sponsor
CSD Labs GmbH
Brief Summary

Background: Computer aided auscultation in the differentiation of pathologic (AHA class I) from no- or innocent murmurs (AHA class III) via artificial intelligence algorithms could be a useful tool to assist healthcare providers in identifying pathological heart murmurs and may avoid unnecessary referrals to medical specialists.

Objective: Assess the quality of the artificial intelligence (AI) algorithm that autonomously detects and classifies heart murmurs as either pathologic (AHA class I) or as no- or innocent (AHA class III).

Hypothesis: The algorithm used in this study is able to analyze and identify pathologic heart murmurs (AHA class I) in an adult population with valve defects with a similar sensitivity compared to medical specialist.

Methods: Each patient is auscultated and diagnosed independently by a medical specialist by means of standard auscultation. Auscultation findings are verified via gold-standard echocardiogram diagnosis. For each patient, a phonocardiogram (PCG) - a digital recording of the heart sounds - is acquired. The recordings are later analyzed using the AI algorithm. The algorithm results are compared to the findings of the medical professionals as well as to the echocardiogram findings.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Adults with a heart defect verified by echocardiography
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity for pathological heart murmur detection2 months

Ability to detect a pathological heart murmur in digital heart sound recordings obtained from an elderly population with heart valve disease.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital

🇦🇹

Graz, Styria, Austria

© Copyright 2025. All Rights Reserved by MedPath